Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zydus Animal Health and Investments is an active Indian public unlisted company within the Zydus group that has operated as the group vehicle for animal health activities and related investments. The company has been described as providing animal healthcare solutions spanning formulations, active pharmaceutical ingredients, wellness products, diagnostics, and other veterinary products, primarily serving India. In 2021, it signed an agreement to divest its India-focused established animal healthcare undertaking to a Multiples-led consortium, indicating that the legal entity remains active while part of its operating business was transferred. More recently, the company has also been used within the Zydus group for investment and shareholding transactions, including the acquisition of shares in Zydus Medtech. Overall, it appears to function as a commercial animal-health and investment subsidiary rather than a clinical-stage biotech developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zydus Animal Health and Investments.